Comments
Lundbeck, Takeda seek FDA approval for new antidepressant drug
02.10.2012. | COPENHAGEN (Reuters) - Danish pharmaceutical group H Lundbeck A/S and its Japanese partner, Takeda Pharmaceutical Co, have submitted an application to the U.S. Food and Drug Administration for approval of its antidepressant, vortioxetine, Lundbeck said on Tuesday....
